StonvexLoading…
StonvexStonvexStonvexCore line items from AIXI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.33M | $70.31M | $59.17M | $48.18M |
Operating Income | $-96.60M | $-12.87M | $-21.92M | $-3.14M |
Net Income | $-101.22M | $-14.51M | $-26.46M | $-5.90M |
EPS (Diluted) | $-2.44 | $-0.56 | $-1.12 | $-0.27 |
Total Assets | $15.90M | $85.51M | $66.33M | $60.58M |
Total Liabilities | $120.77M | $101.28M | $74.80M | $69.57M |
Cash & Equivalents | $2.32M | $846.59K | $1.56M | $1.03M |
Free Cash Flow OCF − CapEx | $-3.73M | $-15.51M | $-17.95M | $-11.03M |
Shares Outstanding | 55.24M | 31.95M | 24.02M | 22.12M |